Cargando…
Suppression of CD13 Enhances the Cytotoxic Effect of Chemotherapeutic Drugs in Hepatocellular Carcinoma Cells
Multidrug resistance (MDR) of hepatocellular carcinoma (HCC) is a serious problem that directly hinders the effect of chemotherapeutics. In this study, we mainly explore the molecular mechanism of ROS-induced CD13 expression using hepatocarcinoma cells as the research object. We show that the drug o...
Autores principales: | Ji, Shengping, Ma, Yuqian, Xing, Xiaoyan, Ge, Binbin, Li, Yutian, Xu, Xinyue, Song, Jiliang, Xiao, Mei, Gao, Feng, Jiang, Wenyan, Fang, Chunyan, Wang, Xuejian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8144446/ https://www.ncbi.nlm.nih.gov/pubmed/34045966 http://dx.doi.org/10.3389/fphar.2021.660377 |
Ejemplares similares
-
CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents
por: Zhang, Jian, et al.
Publicado: (2018) -
Chemotherapeutic Nanoparticle-Based Liposomes Enhance the Efficiency of Mild Microwave Ablation in Hepatocellular Carcinoma Therapy
por: Wu, Songsong, et al.
Publicado: (2020) -
Chemotherapeutic drugs for soft tissue sarcomas: a review
por: Tian, Zhichao, et al.
Publicado: (2023) -
Chemotherapeutics-Induced Intestinal Mucositis: Pathophysiology and Potential Treatment Strategies
por: Dahlgren, David, et al.
Publicado: (2021) -
Exploring the chemotherapeutic potential of currently used kinase inhibitors: An update
por: Naik, Rajashri R., et al.
Publicado: (2023)